EXHIBIT 107

Calculation Of Filing Fee Tables

Form S-3

(Form Type)

Sutro Biopharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security
Type
  Security
Class
Title
  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price
Per Unit
 

Maximum
Aggregate
Offering

Price

  Fee
Rate
  Amount of
Registration
Fee
  Carry
Forward
Form
Type
  Carry
Forward
File
Number
  Carry
Forward
Initial
Effective
Date
  Filing Fee
Previously
Paid in
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                         
Fees to be
Paid
  Equity   Common stock,
par value $0.001 per share
  457(o)                    
  Equity   Preferred stock,
par value $0.001
per share
  457(o)                                    
  Debt   Debt securities   457(o)                                    
  Other   Warrants   457(o)                                    
  Other   Subscription Rights   457(o)                                    
  Other   Units   457(o)                                    
 

Unallocated

(Universal) Shelf

    457(o)   $50,000,000(1)   N/A(2)   $50,000,000   $0.00014760   $7,380                
 
Carry Forward Securities
                         
Carry
Forward
Securities
  Equity   Common stock,
par value $0.001 per share
  415(a)(6)                    
  Equity   Preferred stock,
par value $0.001
per share
  415(a)(6)                                    
  Debt   Debt securities   415(a)(6)                                    
  Other   Warrants   415(a)(6)                                    
  Other   Subscription Rights   415(a)(6)                                    
  Other   Units   415(a)(6)                                    
 

Unallocated

(Universal) Shelf

    415(a)(6)   $250,000,000(1)   N/A(2)   $250,000,000   $0.0000927       S-3   333-255014   February 28, 2022   $23,175
                   
    Total Offering Amounts     $300,000,000(3)              
                   
    Total Fees Previously Paid                  
                   
    Total Fee Offsets                  
                   
    Net Fee Due       $7,380                        

 

(1)

There is being registered hereunder an indeterminate number of shares of (a) common stock, (b) preferred stock, (c) debt securities, (d) warrants to purchase common stock, preferred stock or debt securities of the Registrant, (e) subscription rights to purchase common stock, preferred stock or debt securities of the Registrant, and (f) units, consisting of some or all of these securities in any combination, as may be sold from time to time by the Registrant. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. There is also being registered hereunder an indeterminate number of shares of common stock, preferred stock and debt securities as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance. In no event will the aggregate offering price of all types of securities issued by the Registrant pursuant to this registration statement exceed $300,000,000. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, or the Securities Act, this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction.

(2)

The proposed maximum offering price per share and proposed maximum aggregate offering price for each type of security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act.

(3)

The $300,000,000 of securities registered pursuant to this registration statement includes $250,000,000 of securities (the “Unsold Securities”) registered pursuant to the Registration Statement on Form S-3 (No. 333-255014), filed on February 28, 2022, as amended. Pursuant to Rule 415(a)(6) under the Securities Act, the filing fees previously paid in connection with the Unsold Securities will continue to be applied to the Unsold Securities.